Source:
TheHillA deal between the White House and the pharmaceutical industry is holding up a bipartisan amendment to allow the importation of cheaper prescription drugs from abroad, according to a member of the Senate Democratic leadership.
The Senate has been debating the amendment, sponsored by Sen. Byron Dorgan (D-N.D.), since Tuesday but has not held a vote, which is contributing to a stall in the floor action on healthcare reform.
Dorgan’s measure, which would permit bulk exports of medicines from countries such as Canada,
enjoys broad and bipartisan support and likely has the backing of more than 60 senators, which would guarantee its adoption on the healthcare reform bill.
Tension between the White House and Democratic supporters of the so-called drug reimportation amendment is primarily behind the delay, Senate Majority Whip Dick Durbin (D-Ill.) said Thursday.
“There’s a political subtext here,” Durbin said. “It has to do with whether or not we can do as part of the impact on pharma in this bill and whether or not there are other things that are higher priorities.”
The White House and the Pharmaceutical Research and Manufacturers of America (PhRMA) struck a deal this summer to limit the drug industry’s financial exposure under reform to $80 billion over 10 years, though its terms have never been fully disclosed.
President Barack Obama was one of the 35 co-sponsors of Dorgan’s drug reimportation legislation when Obama served in the Senate. In addition, White House Chief of Staff Rahm Emanuel was a leading supporter of the House version of the bill when he served in the lower chamber.
“Many of us support it but wonder if this is the right venue,” Durbin said, but “we don’t want to slow down this bill or stop it over what is an important issue but, I think, takes second place to the overall healthcare reform.”
Asked Wednesday whether the Democratic leadership was whipping its members to support or oppose the Dorgan amendment, Durbin said, “Well, we asked. There was a question asked of members through staff as to how they were inclined but it isn’t like we’re buttonholing people, yes or no, and saying ‘Vote the other way.’”
Several Democratic senators are objecting to moving ahead with the vote because they believe the amendment has enough support to prevail, said Sen. Olympia Snowe (R-Maine), Dorgan’s lead co-sponsor.
“I suspect we haven't had a vote yet because they know it has the votes to pass,” she said.
Read more:
http://thehill.com/homenews/senate/71767-pharmaceutical-deal-holding-up-bipartisan-health-amendment
Ask not, what you can do for your country, ask what's in it for Big Pharma.. :patriot: :puke: